Skip to main content
. 2020 Oct 20;63(21):12773–12785. doi: 10.1021/acs.jmedchem.0c01107

Table 1. Inhibitory Potencies of the Parent, Precursors, and Bivalent Ligands at hNaV1.4 and hNaV1.7a.

  Ligand IC50 (nM ± SEM) IC50 relative to 1 n
hNaV1.4
  Bivalent ligands      
1 [m3-HwTx-IV]-[PEG80]-[K-KIIIA] 9 ± 1 1 3
2 [m3-HwTx-IV]-[PEG60]-[K-KIIIA] 14 ± 1 1.6× ↑ 3
3 [m3-HwTx-IV]-[PEG120]-[K-KIIIA] 13 ± 3 1.4× ↑ 3
  Controls      
4 [m3-HwTx-IV]-[PEG40]-[K-KIIIA] 29 ± 5 3.2× ↑ 4
5 AzK-KIIIA/S-m3-HwTx-IV 33 ± 8 3.7× ↑ 3
6 AzK-KIIIA 32 ± 10 3.6× ↑ 3
7 μ-KIIIA30 48 ± 6b 5.3× ↑ 3
8 [K-KIIIA]-[PEG80] 144 ± 46 16.0× ↑ 4
9 S-m3-HwTx-IV 212 ± 20 23.6× ↑ 4
10 m3-HwTx-IV36 369 ± 196c 41.0× ↑ 6
11 HwTx-IV49 400 ± nab 44.4× ↑ 3
12 [m3-HwTx-IV]-[PEG80] 409 ± 64 45.4× ↑ 4
hNaV1.7
  Bivalent ligand      
1 [m3-HwTx-IV]-[PEG80]-[K-KIIIA] 6 ± 0.1 1 3
  Controls      
4 [m3-HwTx-IV]-[PEG40]-[K-KIIIA] 6 ± 2 no change 4
5 AzK-KIIIA/S-m3-HwTx-IV 6 ± 1 no change 3
6 AzK-KIIIA 96 ± 41 16.0× ↑ 3
7 μ-KIIIA 132 ± 37 22.0× ↑ 4
9 S-m3-HwTx-IV 4 ± 0.3 1.5x ↓ 4
10 m3-HwTx-IV34 0.4 ± 0.1 15.0× ↓ 6
11 HwTx-IV34 17 ± 2 2.8× ↑ 10
12 [m3-HwTx-IV]-[PEG80] 8 ± 1 1.3× ↑ 4
a

n is the number of cells, with each cell considered an independent experiment.

b

IC50 values were determined on rat NaV channel.

c

The IC50 value was determined for the peptide with no C-terminal amidation. Legend: n.a., not available; ↑, fold increase in IC50 relative to ligand 1; ↓, fold decrease in IC50 relative to ligand 1.